Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sorrento Therpt (SRNE)

Sorrento Therpt (SRNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Dr. Henry Ji to Participate in the H.C. Wainwright Virtual GLOBAL LIFE SCIENCES CONFERENCE 2021 Investor Conference

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming conference:

SRNE : 8.68 (-1.48%)
Sorrento Therapeutics (SRNE) Stock Sinks As Market Gains: What You Should Know

Sorrento Therapeutics (SRNE) closed at $10.97 in the latest trading session, marking a -0.32% move from the prior day.

SRNE : 8.68 (-1.48%)
Sorrento Therape Has Returned 47.5% Since SmarTrend Recommendation (SRNE)

SmarTrend identified an Uptrend for Sorrento Therape (NASDAQ:SRNE) on November 19th, 2020 at $7.41. In approximately 3 months, Sorrento Therape has returned 47.47% as of today's recent price of $10.92....

SRNE : 8.68 (-1.48%)
Sorrento Therapeutics (SRNE) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Sorrento Therapeutics (SRNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SRNE : 8.68 (-1.48%)
Thinking about buying stock in GameStop, Verb Technology, Brickell Biotech, Creative Realities, or Sorrento Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GME, VERB, BBI, CREX, and SRNE.

CREX : 2.37 (-10.57%)
BBI : 1.0999 (-5.18%)
VERB : 1.84 (-10.24%)
SRNE : 8.68 (-1.48%)
GME : 140.50 (+6.16%)
Scoop: UPS pilots try rapid COVID test to avoid Hong Kong quarantines

Air crews don’t like flying to Hong Kong these days because COVID testing there is invasive and they could end up in mass quarantine facilities. UPS pilots are testing a new rapid antigen test that could...

SRNE : 8.68 (-1.48%)
UPS : 163.00 (+2.23%)
Sorrento Therapeutics (SRNE) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Sorrento Therapeutics (SRNE) closed at $13.98, marking a -0.71% move from the previous day.

SRNE : 8.68 (-1.48%)
Sorrento (SRNE) to Report Q4 Earnings: What's in the Cards?

Sorrento (SRNE) will provide updates on sales, earnings and pipeline when it reports fourth-quarter 2020 results.

ADMA : 2.07 (-7.17%)
SRNE : 8.68 (-1.48%)
AVIR : 60.12 (-4.63%)
CSTL : 66.81 (-2.14%)
Uptrend Call Working As Sorrento Therape Stock Rises 94.3% (SRNE)

SmarTrend identified an Uptrend for Sorrento Therape (NASDAQ:SRNE) on November 19th, 2020 at $7.41. In approximately 3 months, Sorrento Therape has returned 94.33% as of today's recent price of $14.39....

SRNE : 8.68 (-1.48%)
Lee's Pharmaceutical Announces Its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Breakthrough Therapy Designation in China for the Treatment of Recurrent or Metastatic Cervical Cancer

China Oncology Focus Limited (COF), an affiliate of Lee's Pharmaceutical Holdings Limited (Lee's Pharma, HKEX: 950), and Sorrento Therapeutics, Inc. (Sorrento, Nasdaq: SRNE), today announced that its anti-PD-L1...

SRNE : 8.68 (-1.48%)
Shares of SRNE Up 90.5% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Sorrento Therape (NASDAQ:SRNE) on November 19th, 2020 at $7.41. In approximately 3 months, Sorrento Therape has returned 90.55% as of today's recent price of $14.11....

SRNE : 8.68 (-1.48%)
High COVID-19 Vaccine Uptake Proving Critical for Achieving Individual and Population Immunity

PALM BEACH,  Fla., /PRNewswire/ -- Recent reports of ongoing testing regarding the length of time that the initially approved vaccines for COVID-19 will give the patients for immunity after having been...

BIOV.CN : 0.445 (+7.23%)
LMNGF : 0.3535 (+7.12%)
INO : 9.30 (+1.64%)
DVAX : 7.91 (-6.61%)
NVAX : 172.81 (+9.30%)
SRNE : 8.68 (-1.48%)
Pan American, Sorrento rise; Lumen Technologies, PVH fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:

PAAS.TO : 38.82 (-0.89%)
PVH : 102.55 (+3.01%)
IFF : 134.29 (+2.60%)
SRNE : 8.68 (-1.48%)
ON : 38.34 (+3.51%)
Thinking about buying stock in First Majestic Silver, Dynavax Technologies, AMC Entertainment, McEwen Mining, or Sorrento Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AG, DVAX, AMC, MUX, and SRNE.

AC : 33.90 (-0.56%)
MUX.TO : 1.34 (-2.90%)
DVAX : 7.91 (-6.61%)
SRNE : 8.68 (-1.48%)
AG : 15.94 (-0.81%)
AMC : 7.99 (-0.50%)
MUX : 1.0550 (-2.31%)
Thinking about buying stock in Nokia, Sorrento Therapeutics, BlackBerry, Viveve Medical, or Jaguar Health?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NOK, SRNE, BB, VIVE, and JAGX.

JAGX : 1.4950 (-7.14%)
SRNE : 8.68 (-1.48%)
VIVE : 2.81 (-6.95%)
BB : 9.31 (-5.39%)
NOK : 3.87 (+1.31%)
Thinking about buying stock in Nokia, AMC Entertainment, BlackBerry, Northern Dynasty Minerals, or Sorrento Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NOK, AMC, BB, NAK, and SRNE.

AC : 33.90 (-0.56%)
NAK : 0.6399 (+1.57%)
SRNE : 8.68 (-1.48%)
AMC : 7.99 (-0.50%)
BB : 9.31 (-5.39%)
NOK : 3.87 (+1.31%)
Studies Indicating T-Cells May Be Needed For Long-Term Protection From The SARS-Cov-2 Virus

, /PRNewswire/ -- According to the National Institutes of Health (NIH), the tide in the global fight against COVID-19, the disease caused by the SARS-CoV-2 virus, may soon begin to turn. Last month, three...

BIOV.CN : 0.445 (+7.23%)
LMNGF : 0.3535 (+7.12%)
SRNE : 8.68 (-1.48%)
INO : 9.30 (+1.64%)
CYDY : 4.3100 (+6.16%)
NVAX : 172.81 (+9.30%)
Sorrento Therape Has Returned 78.9% Since SmarTrend Recommendation (SRNE)

SmarTrend identified an Uptrend for Sorrento Therape (NASDAQ:SRNE) on November 19th, 2020 at $7.41. In approximately 2 months, Sorrento Therape has returned 78.93% as of today's recent price of $13.25....

SRNE : 8.68 (-1.48%)
Thinking about buying stock in Clovis Oncology, Ashford Hospitality Trust, Atara Biotherapeutics, Sorrento Therapeutics, or Vertex Energy?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLVS, AHT, ATRA, SRNE, and VTNR.

ATRA : 16.14 (+1.57%)
CLVS : 5.44 (-3.89%)
SRNE : 8.68 (-1.48%)
VTNR : 1.4200 (-1.76%)
AHT : 2.64 (-1.12%)
Scientists Still Relentlessly Working to Develop Newest, More Advanced Antiviral Therapies for COVID-19 Treatments

, /PRNewswire/ -- The antivirals market consists of sales of antiviral drugs and related services. Antiviral drugs reduce the replication of viruses at different stages. Various type of viral infections...

NNVC : 4.95 (+6.45%)
TTOO : 1.6250 (-16.67%)
PFE : 34.21 (+0.03%)
SRNE : 8.68 (-1.48%)
MRNA : 131.73 (-0.43%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar